Polycyclic aromatic hydrocarbons (PAHs) may cause lipid peroxidation via reactive oxygen species generation. 15-F2t-isoprostane (IsoP), an oxidative stress marker, is formed from arachidonic acid (AA) by a free-radical induced oxidation. AA may also be converted to prostaglandins (PG) by prostaglandin-endoperoxide synthase (PTGS) induced by NF-κB. We treated human embryonic lung fibroblasts (HEL12469) with benzo[a]pyrene (B[a]P), 3-nitrobenzanthrone (3-NBA) and extractable organic matter (EOM) from ambient air particulate matter <2.5 µm for 4 and 24 h. B[a]P and 3-NBA induced expression of PAH metabolising, but not antioxidant enzymes. The concentrations of IsoP decreased, whereas the levels of AA tended to increase. Although the activity of NF-κB was not detected, the tested compounds affected the expression of prostaglandin-endoperoxide synthase 2 (PTGS2). The levels of prostaglandin E2 (PGE2) decreased following exposure to B[a]P, whereas 3-NBA exposure tended to increase PGE2 concentration. A distinct response was observed after EOM exposure: expression of PAH-metabolising enzymes was induced, IsoP levels increased after 24-h treatment but AA concentration was not affected. The activity of NF-κB increased after both exposure periods, and a significant induction of PTGS2 expression was found following 4-h treatment. Similarly to PAHs, the EOM exposure was associated with a decrease of PGE2 levels. In summary, exposure to PAHs with low pro-oxidant potential results in a decrease of IsoP levels implying 'antioxidant' properties. For such compounds, IsoP may not be a suitable marker of lipid peroxidation.

Department of Chemistry and Toxicology Veterinary Research Institute Brno Czech Republic

Department of Genetic Toxicology and Nanotoxicology Institute of Experimental Medicine of the Czech Academy of Sciences Prague Czech Republic

Department of Genetic Toxicology and Nanotoxicology Institute of Experimental Medicine of the Czech Academy of Sciences Prague Czech Republic Department of Physiology Faculty of Science Charles University Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc20023932

003      

CZ-PrNML

005      

20201214131743.0

007      

ta

008      

201125s2019 xxk f 000 0|eng||

009      

AR

024    7_

$a 10.1093/mutage/gez004 $2 doi

035    __

$a (PubMed)30852615

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxk

100    1_

$a Rossner, Pavel $u Department of Genetic Toxicology and Nanotoxicology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.

245    14

$a The processes associated with lipid peroxidation in human embryonic lung fibroblasts, treated with polycyclic aromatic hydrocarbons and organic extract from particulate matter / $c P. Rossner, H. Libalova, T. Cervena, K. Vrbova, F. Elzeinova, A. Milcova, A. Rossnerova, Z. Novakova, M. Ciganek, M. Pokorna, A. Ambroz, J. Topinka,

520    9_

$a Polycyclic aromatic hydrocarbons (PAHs) may cause lipid peroxidation via reactive oxygen species generation. 15-F2t-isoprostane (IsoP), an oxidative stress marker, is formed from arachidonic acid (AA) by a free-radical induced oxidation. AA may also be converted to prostaglandins (PG) by prostaglandin-endoperoxide synthase (PTGS) induced by NF-κB. We treated human embryonic lung fibroblasts (HEL12469) with benzo[a]pyrene (B[a]P), 3-nitrobenzanthrone (3-NBA) and extractable organic matter (EOM) from ambient air particulate matter <2.5 µm for 4 and 24 h. B[a]P and 3-NBA induced expression of PAH metabolising, but not antioxidant enzymes. The concentrations of IsoP decreased, whereas the levels of AA tended to increase. Although the activity of NF-κB was not detected, the tested compounds affected the expression of prostaglandin-endoperoxide synthase 2 (PTGS2). The levels of prostaglandin E2 (PGE2) decreased following exposure to B[a]P, whereas 3-NBA exposure tended to increase PGE2 concentration. A distinct response was observed after EOM exposure: expression of PAH-metabolising enzymes was induced, IsoP levels increased after 24-h treatment but AA concentration was not affected. The activity of NF-κB increased after both exposure periods, and a significant induction of PTGS2 expression was found following 4-h treatment. Similarly to PAHs, the EOM exposure was associated with a decrease of PGE2 levels. In summary, exposure to PAHs with low pro-oxidant potential results in a decrease of IsoP levels implying 'antioxidant' properties. For such compounds, IsoP may not be a suitable marker of lipid peroxidation.

650    _2

$a látky znečišťující vzduch $x toxicita $7 D000393

650    _2

$a kyselina arachidonová $x metabolismus $7 D016718

650    _2

$a aromatické hydroxylasy $x metabolismus $7 D001189

650    _2

$a benz(a)anthraceny $x toxicita $7 D001551

650    _2

$a benzopyren $x toxicita $7 D001564

650    _2

$a kultivované buňky $7 D002478

650    _2

$a cyklooxygenasa 2 $x metabolismus $7 D051546

650    _2

$a dinoprost $x analogy a deriváty $x biosyntéza $x metabolismus $7 D015237

650    _2

$a dinoproston $x biosyntéza $x metabolismus $7 D015232

650    _2

$a fibroblasty $x účinky léků $x enzymologie $7 D005347

650    _2

$a lidé $7 D006801

650    _2

$a peroxidace lipidů $x účinky léků $7 D015227

650    _2

$a plíce $x cytologie $x účinky léků $x embryologie $x enzymologie $7 D008168

650    _2

$a NF-kappa B $x metabolismus $7 D016328

650    _2

$a oxidační stres $x účinky léků $7 D018384

650    _2

$a pevné částice $x toxicita $7 D052638

650    _2

$a polycyklické aromatické uhlovodíky $x toxicita $7 D011084

650    _2

$a reaktivní formy kyslíku $x metabolismus $7 D017382

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Libalova, Helena $u Department of Genetic Toxicology and Nanotoxicology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.

700    1_

$a Cervena, Tereza $u Department of Genetic Toxicology and Nanotoxicology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic. Department of Physiology, Faculty of Science, Charles University, Prague, Czech Republic.

700    1_

$a Vrbova, Kristyna $u Department of Genetic Toxicology and Nanotoxicology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.

700    1_

$a Elzeinova, Fatima $u Department of Genetic Toxicology and Nanotoxicology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.

700    1_

$a Milcova, Alena $u Department of Genetic Toxicology and Nanotoxicology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.

700    1_

$a Rossnerova, Andrea $u Department of Genetic Toxicology and Nanotoxicology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.

700    1_

$a Novakova, Zuzana $u Department of Genetic Toxicology and Nanotoxicology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.

700    1_

$a Ciganek, Miroslav $u Department of Chemistry and Toxicology, Veterinary Research Institute, Brno, Czech Republic.

700    1_

$a Pokorna, Michaela $u Department of Genetic Toxicology and Nanotoxicology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.

700    1_

$a Ambroz, Antonin $u Department of Genetic Toxicology and Nanotoxicology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.

700    1_

$a Topinka, Jan $u Department of Genetic Toxicology and Nanotoxicology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.

773    0_

$w MED00003429 $t Mutagenesis $x 1464-3804 $g Roč. 34, č. 2 (2019), s. 153-164

856    41

$u https://pubmed.ncbi.nlm.nih.gov/30852615 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20201125 $b ABA008

991    __

$a 20201214131741 $b ABA008

999    __

$a ok $b bmc $g 1596251 $s 1114608

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2019 $b 34 $c 2 $d 153-164 $e 20190529 $i 1464-3804 $m Mutagenesis $n Mutagenesis $x MED00003429

LZP    __

$a Pubmed-20201125